CME GROUP INC. (CME) FY2025 Q2 Balance Sheet

CME GROUP INC. (CME) FY2025 Q2 Balance Sheet

Balance sheet as of 2025-06-30. The chart shows assets, liabilities and equity at that date.

Assets

179,907,000,000 US dollars

Current assets

145,450,100,000 US dollars

Non-current assets

34,456,900,000 US dollars

Liabilities

152,168,000,000 US dollars

Current liabilities

142,794,800,000 US dollars

Non-current liabilities

9,373,200,000 US dollars

Equity

27,739,000,000 US dollars

Performance bonds and guaranty fund contributions

142,158,000,000 US dollars

Cash and cash equivalents

1,981,300,000 US dollars

Accounts receivable, net of allowance of $9.9 and $9.0

667,600,000 US dollars

Other current assets (includes $6.5 and $6.3 in restricted cash)

525,600,000 US dollars

Marketable securities

117,600,000 US dollars

Intangible assets—trading products

17,175,300,000 US dollars

Goodwill

10,523,900,000 US dollars

Other assets

3,666,300,000 US dollars

Intangible assets—other, net

2,728,500,000 US dollars

Property, net of accumulated depreciation and amortization of $960.8 and $1,024.3

362,900,000 US dollars

Performance bonds and guaranty fund contributions

142,158,000,000 US dollars

Other current liabilities

544,500,000 US dollars

Accounts payable

92,300,000 US dollars

Short-term Debt

0 US dollars

Deferred income tax liabilities, net

5,232,600,000 US dollars

Long-term debt

3,420,400,000 US dollars

Other liabilities

720,200,000 US dollars

Additional paid-in capital

22,435,100,000 US dollars

Retained earnings

5,254,900,000 US dollars

Accumulated other comprehensive income (loss)

45,400,000 US dollars

Common stock - Class A Common Stock

3,600,000 US dollars

Common stock - Class B Common Stock

0 US dollars

Preferred stock, $0.01 par value, 10,000 shares authorized as of June 30, 2025 and December 31, 2024; 4,584 issued and outstanding as of June 30, 2025 and December 31, 2024

0 US dollars

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.